Abstract
Objective:
To evaluate whether Rh-positive preterm newborn infants born to Rh-negative mothers treated with prophylactic anti-D immunoglobulins exhibited signs of hemolytic reaction, including anemia and hyperbilirubinemia.
Study design:
Retrospective data were collected for 94 Rh-positive preterm newborns born at gestational age (GA) 28 to 34 weeks to 76 Rh-negative mothers and for matched controls.
Result:
We found 11.7% positive Coombs’ tests among infants in the study group and slightly higher bilirubin levels at birth and on the following 3 days. No differences were recorded between the study and the control groups for hematocrit levels throughout hospitalization, maximal bilirubin level, phototherapy treatment or the need for blood transfusion.
Conclusion:
Among preterm Rh-positive newborn infants born to Rh-negative mothers, there appears to be no evidence of significant hemolytic reaction derived from placental anti-D transfer. Further prospective studies are needed to confirm these findings in order to support anti-D administration close to preterm birth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
National Institute for Clinical Excellence. Pregnancy—routine antenatal anti-D prophylaxis for women who are rhesus negative. Review of NICE Technology Appraisal 41. NICE Technology Appraisal 156 http://www.nice.org.uk/TA156. 2008 (accessed 1 July 2010).
Bowman JM Editorial. Prevention of Rh immunization. Can Med Assoc J 1970; 103, pp 1810–1811.
James RM, McGuire W, Smith DP . The investigation of infants with RhD-negative mothers: can we safely omit the umbilical cord blood direct antiglobulin test? Arch Dis Child Fetal Neonatal Ed 2011; 96: F301–F304.
Maayan-Metzger A, Schwartz T, Sulkes J, Merlob P . Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis. Arch Dis Child Fetal Neonatal Ed 2001; 84: F60–F62.
Maisels MJ . Jaundice In: MacDonald MG, Seshia MMK, Mullett MD (eds). Avery’s Neonatology, 6th edn, Lippincott Williams&Wilkins: Philadelphia, 2005, pp 768–818.
Madan A, MacMahon JR, Stevenson DK . Neonatal hyperbilirubinemia In: Taeusch HW, Ballard RA, Gleason CA (eds). Avery’s Diseases of the Newborn, 8th edn, Elsevier Saunders: Philadelphia, 2005, pp 1246–1247.
Wong RJ, DeSandre GH, Sibley E, Stevenson DK . Neonatal jaundice and liver disease In: Martin RJ, Fanaroff AA, Walsh MC eds. Fanaroff and Martin’s Neonatal-Perinatal Medicine 8th edn, Mosby Elsevier: Philadelphia, 2006, pp 1446–1450.
Brinc D, Lazarus AH . Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematology Am Soc Hematol Educ Program 2009; 2009 (1) 185–191.
Kumpel BM, Elson CJ . Mechanism of anti-D-mediated immune suppression–a paradox awaiting resolution? Trends Immunol 2001; 22 (1): 26–31.
Chown B, Bowman JM, Pollock J, Lowen B, Pettett A . The effect of anti-D IgG on D-positive recipients. Can Med Assoc J 1970; 102 (11): 1161–1164.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Maayan-Metzger, A., Leibovitch, L., Schushan-Eisen, I. et al. Maternal anti-D prophylaxis during pregnancy and risk of hemolysis among preterm infants. J Perinatol 34, 906–908 (2014). https://doi.org/10.1038/jp.2014.134
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2014.134